Emerging Research on Micro-Dosing GLP-1 Agonists Recent studies are exploring the benefits of micro-dosing GLP-1 medications, such as weight loss peptides and tirzepatide
While all types of may technically help with both, the three FDA-approved options are intended for different purposes
Physician 10 (4), 66726681
The researchers were careful to make sure both groups ate at the same rate, because eating even the exact same food more slowly can result in a greater GLP-1 response
In that report, the incidence of pancreatic cancer was also 2.9 and 2.7 times greater with exenatide and sitagliptin, respectively, compared to other oral antidiabetic medications
Mehmet Oz, professor emeritus at Columbia University and global advisor for iHerb